International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung cancer: MONET1. (Q34285538)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung cancer: MONET1. |
scientific article |
Statements
International, randomized, placebo-controlled, double-blind phase III study of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous non-small-cell lung cancer: MONET1 (English)
Giorgio V Scagliotti
Keunchil Park
Yukito Ichinose
Kaoru Kubota
Robert Pirker
Rinat Galiulin
Tudor-Eliade Ciuleanu
Oleksandr Sydorenko
Mircea Dediu
Zsolt Papai-Szekely
Natividad Martinez Banaclocha
Sheryl McCoy
Bin Yao
Yong-Jiang Hei
Francesco Galimi
David R Spigel